Loading
Yanuki
KEYWORD TOPIC
Wave Life Sciences Plunges After Obesity Data | Wave Life Sciences' RNA Obesity Shot Shows Promising Results | Wave Life Sciences Plunges After Obesity Data | Wave Life Sciences' RNA Obesity Shot Shows Promising Results

Healthcare / Obesity Treatment

Wave Life Sciences Plunges After Obesity Data

Wave Life Sciences (WVE) stock plummeted after the release of interim data from an early-stage trial of its RNA-based obesity medicine, WVE-007. The trial data, focusing on healthy individuals, led to a sharp negative reaction from Wall Str...

Wave Life Sciences plunges after obesity data (WVE:NASDAQ)
Wave Life Sciences Plunges After Obesity Data Image via Seeking Alpha
TOPIC wve stock

Health / Weight Loss

Wave Life Sciences' RNA Obesity Shot Shows Promising Results

Wave Life Sciences (Nasdaq: WVE) has announced positive interim data from its Phase 1 INLIGHT trial of WVE-007 (INHBE), an investigational RNA medicine for treating obesity. The single-dose study demonstrated significant improvements in bod...

Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss